The Combination of Rad001 and Rituximab In Patients With Non-hodgkin's Lymphomas
NCT01567475
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
21
Enrollment
OTHER
Sponsor class
Conditions
Non-Hodgkin's Lymphomas
Interventions
DRUG:
Everolimus and rituximab
Sponsor
The Lymphoma Academic Research Organisation